These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia? Bèïque L; Por CP; Evans MF Can Fam Physician; 1998 Dec; 44():2659-62. PubMed ID: 9870119 [No Abstract] [Full Text] [Related]
10. [Alpha blockers in the treatment of benign hyperplasia of the prostate]. Gómez Sancha F; Fernández Arjona M; Peinado Ibarra F; Fernández Borrell A; Mínguez Martínez R; Pereira Sanz I Rev Clin Esp; 1997 May; 197(5):358-62. PubMed ID: 9280971 [No Abstract] [Full Text] [Related]
11. Treatment of benign prostatic hyperplasia and hypertension in elderly hypertensive patients. Suzuki H Br J Urol; 1998 Mar; 81 Suppl 1():51-5. PubMed ID: 9589018 [No Abstract] [Full Text] [Related]
12. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study]. Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599 [No Abstract] [Full Text] [Related]
13. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas]. Loran OB; Pushkar' DIu; Rasner PI Urologiia; 2000; (2):3-5. PubMed ID: 11186726 [TBL] [Abstract][Full Text] [Related]
15. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Wilde MI; Fitton A; McTavish D Drugs; 1993 Mar; 45(3):410-29. PubMed ID: 7682910 [TBL] [Abstract][Full Text] [Related]
16. [The treatment of patients with benign prostatic hyperplasia using the selective alpha-blocker alfuzosin]. Mazo EB; Matushevskiĭ IA; Nikitin IuIu Ter Arkh; 1997; 69(10):79-82. PubMed ID: 9471799 [TBL] [Abstract][Full Text] [Related]
17. [A clinical trial of the treatment of patients with benign prostatic hyperplasia using the alpha 1-adrenoblocker alfuzosin]. Lopatkin NA; Perepanova TS Urol Nefrol (Mosk); 1997; (5):14-6. PubMed ID: 9412005 [TBL] [Abstract][Full Text] [Related]
18. [The efficacy of alfuzosin (dalfaz) in patients with benign prostatic hyperplasia]. Tkachuk VN; Kuz'min IV Urol Nefrol (Mosk); 1998; (2):38-40. PubMed ID: 9577703 [TBL] [Abstract][Full Text] [Related]
19. Belgian multicenter clinical study of alfuzosin, a selective alpha 1-blocker, in the treatment of benign prostatic hyperplasia. The Alfuzosin Belgian Group. Schulman CC; De Sy W; Vandendris M; Tomas M; Santoni JP Acta Urol Belg; 1994 Dec; 62(4):15-21. PubMed ID: 7540794 [TBL] [Abstract][Full Text] [Related]
20. Bunazosin. Andante, Detantol, E 1015, E 643, EA 0643. Drugs R D; 1999 Dec; 2(6):417-9. PubMed ID: 10763455 [No Abstract] [Full Text] [Related] [Next] [New Search]